Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial

Published:2015-08 Issue: Volume:33 Page:47-51
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Dal Negro R.W.,Visconti M.,Turco P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference30 articles.

1. Preventing Chronic Diseases: a Vital Investment;World Health Organization,2005

2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Update 2013, www.goldcopd.org (accessed March 2015).

3. European Lung White Book: Huddersfield;European Respiratory Society,2003

4. Morbidity and Mortality Chartbook on Cardiovascular, Lung and Blood Diseases;National Heart, Lung, and Blood Institute,2012

5. Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update;Dal Negro;Clin. Outcomes Res.,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target;Respiratory Research;2023-11-24

2. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD;Respiratory Research;2023-07-31

3. Clinical aspects of the use of erdosteine in respiratory diseases;Meditsinskiy sovet = Medical Council;2023-04-12

4. Improved quality of life and dyspnea with erdosteine in COVID-19 patients after hospital discharge;Minerva Respiratory Medicine;2022-05

5. Association Between Extracellular Superoxide Dismutase Activity and 1-Year All-Cause Mortality in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study;Frontiers in Medicine;2022-03-14